Research
Neural
GLP-1 receptor agonists are effective agents for weight loss.
Practitioners can consider GLP-1 receptor agonists as a viable option for weight loss in patients.
StrongSupportsmedium confidence
Recent evidence from clinical trials supports the efficacy and tolerability of glucagon-like peptide 1 (GLP-1) receptor agonists as useful agents for weight loss.
Why this rating
Based on clinical trials mentioned in the abstract.
Source
Slow and Steady Wins the Race: 25 Years Developing the GLP-1 Receptor as an Effective Target for Weight Loss
Nitya Kumar et al. · The Journal of Clinical Endocrinology & Metabolism · 2022
DOI 10.1210/clinem/dgac276
reviewCited 12×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Neural
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →